Caricamento...
Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date
Siponimod (BAF312) is a synthetic molecule belonging to the sphingosine-1-phosphate (S1P) modulator family, which has putative neuroprotective properties and well-characterized immunomodulating effects mediated by sequestration of B and T cells in secondary lymphoid organs. Compared to fingolimod (i...
Salvato in:
| Pubblicato in: | Drug Des Devel Ther |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5679692/ https://ncbi.nlm.nih.gov/pubmed/29138536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S122249 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|